Skip to content
Physician-backed infrastructure for aesthetic & wellness practicesSupport 9 AM–5 PM EST ·(888) 996-6173 ·info@medgrid.com
MedGrid
FDA Daily

FDA daily for Friday, July 24, 2026

269 FDA records across 4 sections. 6 touch MedGrid's categories and are listed first.

269FDA Records
4 of 7Sections With Data
6Touch MedGrid Categories

Sections in This Issue

Drug shortagesCovers FDA's Thu, Jul 23 (yesterday)
15
  • Morphine Sulfate Suppository

    Morphine Sulfate, Suppository, 10 mg (NDC 0574-7112-12) — Padagis US LLC

    New · To Be Discontinued · Analgesia/Addiction

  • Succinylcholine Chloride Injection

    Succinylcholine Chloride, Injection, 20 mg/1 mL (NDC 63323-943-10) — Fresenius Kabi USA, LLC

    New · To Be Discontinued · Anesthesia

  • Hydrocortisone Acetate Suppository

    Hydrocortisone Acetate, Suppository, 25 mg (NDC 0574-7090-12) — Padagis US LLC

    New · To Be Discontinued · Analgesia/Addiction

  • Hydromorphone Hydrochloride Suppository

    Hydromorphone Hydrochloride, Suppository, 3 mg (NDC 0574-7224-06) — Padagis US LLC

    New · To Be Discontinued · Analgesia/Addiction

  • Hydrocortisone Acetate Suppository

    Hydrocortisone Acetate, Suppository, 30 mg (NDC 0574-7093-12) — Padagis US LLC

    New · To Be Discontinued · Analgesia/Addiction

  • Morphine Sulfate Suppository

    Morphine Sulfate, Suppository, 5 mg (NDC 0574-7110-12) — Padagis US LLC

    New · To Be Discontinued · Analgesia/Addiction

  • Morphine Sulfate Suppository

    Morphine Sulfate, Suppository, 30 mg (NDC 0574-7116-12) — Padagis US LLC

    New · To Be Discontinued · Analgesia/Addiction

  • Belladonna and Opium Suppository

    Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-12) — Padagis US LLC

    New · To Be Discontinued · Analgesia/Addiction

  • Morphine Sulfate Suppository

    Morphine Sulfate, Suppository, 20 mg (NDC 0574-7114-12) — Padagis US LLC

    New · To Be Discontinued · Analgesia/Addiction

  • Belladonna and Opium Suppository

    Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12) — Padagis US LLC

    New · To Be Discontinued · Analgesia/Addiction

  • Bendamustine Hydrochloride Injection, Solution

    Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08) — Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.)

    New · To Be Discontinued · Oncology

  • Belladonna and Opium Suppository

    Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-04) — Padagis US LLC

    New · To Be Discontinued · Analgesia/Addiction

Showing 12 of 15. Search the rest in openFDA.

Drug approvalsCovers FDA's Fri, Jul 17 (a week ago)
22
  • DICYCLOMINE HYDROCHLORIDE

    DICYCLOMINE HYDROCHLORIDE — RUBICON RESEARCH

    ANDA216515 · Original approval

  • CELECOXIB

    CELECOXIB — ALEMBIC

    ANDA204519 · Labeling

  • GEMCITABINE HYDROCHLORIDE

    GEMCITABINE HYDROCHLORIDE — ACTAVIS INC

    ANDA204549 · Labeling

  • METHYLPHENIDATE HYDROCHLORIDE

    METHYLPHENIDATE HYDROCHLORIDE — ABHAI LLC

    ANDA206932 · Labeling

  • METFORMIN HYDROCHLORIDE

    METFORMIN HYDROCHLORIDE — TORRENT

    ANDA090014 · Labeling

  • DEXAMETHASONE SODIUM PHOSPHATE

    DEXAMETHASONE SODIUM PHOSPHATE — FRESENIUS KABI USA

    ANDA209192 · Labeling

  • AUGMENTIN '875'

    AMOXICILLIN, CLAVULANATE POTASSIUM — US ANTIBIOTICS

    NDA050720 · Labeling

  • AUGMENTIN '200'

    AMOXICILLIN, CLAVULANATE POTASSIUM — US ANTIBIOTICS

    NDA050726 · Labeling

  • AUGMENTIN '400'

    AMOXICILLIN, CLAVULANATE POTASSIUM — US ANTIBIOTICS

    NDA050725 · Labeling

  • AUGMENTIN ES-600

    AMOXICILLIN, CLAVULANATE POTASSIUM — US ANTIBIOTICS

    NDA050755 · Labeling

  • AUGMENTIN XR

    AMOXICILLIN, CLAVULANATE POTASSIUM — US ANTIBIOTICS

    NDA050785 · Labeling

  • SUBVENITE

    LAMOTRIGINE — OWP PHARMS

    NDA218879 · Labeling

Showing 12 of 22. Search the rest in openFDA.

Drug recallsCovers FDA's Fri, Jul 17 (a week ago)
Nothing from FDA for this date
Food and supplement recallsCovers FDA's Fri, Jul 17 (a week ago)
Nothing from FDA for this date
Device recallsCovers FDA's Fri, Jul 17 (a week ago)
Nothing from FDA for this date
Device clearancesCovers FDA's Fri, Jul 10 (two weeks ago)
16
  • Capenergy C Equipments RF C200 and C400 Drakarian

    Capenergy Medical S.L.

    K253480 · Substantially Equivalent · General, Plastic Surgery

  • Electric Wheelchair (DY611A-2, DY612A-1)

    Zhejiang Lumbre Electric Appliance Co., Ltd.

    K261149 · Substantially Equivalent · Physical Medicine

  • Omnifit® 20° Series I Insert;Omnifit® Crossfire® 10° Series II Insert; Constrained Acetabular Insert; Trident® Crossfir…

    Howmedica Osteonics Corp., Dba Stryker Orthopaedics

    K261624 · Substantially Equivalent · Orthopedic

  • ClearSafe Closed System

    MedSource Labs, LLC

    K261041 · Substantially Equivalent · General Hospital

  • AI Contouring (VA10A)

    Varian Medical Systems

    K261306 · Substantially Equivalent · Radiology

  • NYES Tuff Cuff L3 Disposable Gowns

    New York Embroidery Studio

    K261949 · Substantially Equivalent · General, Plastic Surgery

  • SmartCT (R3.0 (L10))

    Philips Medical Systems B.V.

    K253670 · Substantially Equivalent · Radiology

  • Sofia Lyme FIA; Sofia 2 Campylobacter FIA

    Ortho-Clinical Diagnostics, Inc. (QuidelOrtho)

    K254295 · Substantially Equivalent · Microbiology

  • Flowflex Plus RSV + Flu A/B + COVID Rapid Test

    ACON Laboratories, Inc.

    K261212 · Substantially Equivalent · Microbiology

  • LungFlow Airway Catheter

    Free Flow Medical, Inc.

    K254037 · Substantially Equivalent · Ear, Nose, Throat

  • WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System

    Boston Scientific Corporation

    K261978 · Substantially Equivalent · General, Plastic Surgery

  • Minnesota Four-Lumen Esophagogastric Tamponade Tube - 18 French (0092220); Blakemore Esophageal-Nasogastric Tube - 20 F…

    C.R. Bard, Inc.

    K253514 · Substantially Equivalent · Gastroenterology, Urology

Showing 12 of 16. Search the rest in openFDA.

Label changesCovers FDA's Fri, Jul 10 (two weeks ago)
6 touch MedGrid216
  • LIDOCAINE HYDROCHLORIDETouches MedGrid categories

    HF Acquisition Co LLC, DBA HealthFirst

    Label version 3

  • XeominTouches MedGrid categories

    Merz North America, Inc.

    Label version 27

  • Nicotine Transdermal System Patch Step 3Touches MedGrid categories

    BluePoint Laboratories

    Label version 3

  • Zmztuhua Numbing CreamTouches MedGrid categories

    Guangzhou Hechuang Commercial Service Co.,Ltd.

    Label version 1

  • VERSED DAILY SUNSCREEN SPF 50Touches MedGrid categories

    COSMAX USA, CORP

    Label version 1

  • Protect Sport SunscreenTouches MedGrid categories

    Opal Day Spa

    Label version 1

  • Lubiprostone

    Dr. Reddy's Laboratories Inc.

    Label version 4

  • FARXIGA

    A-S Medication Solutions

    Label version 22

  • Irbesartan

    REMEDYREPACK INC.

    Label version 11

  • Ibuprofen

    Cardinal Health 107, LLC

    Label version 1

  • Drug label

    Label version 4

  • Aripiprazole

    ATLANTIC BIOLOGICALS CORP.

    Label version 2

Showing 12 of 216. Search the rest in openFDA.

How the FDA Daily Is WrittenSources, dates and what gets flagged

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug recalls, device recalls and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Items that touch the categories MedGrid works in, such as GLP-1s, hormones, injectables, peptides, compounded products and aesthetic devices, are marked and listed first.

Subscribe with any feed reader, or point an email tool at theRSS feed. For the rules behind the headlines, see Regulations Research.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.